| Knarik Yegiazaryan, PHARMD | |
|
1600 Eureka Rd, Roseville, CA 95661-3027 | |
| (916) 784-4000 | |
| Not Available |
| Full Name | Knarik Yegiazaryan |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1600 Eureka Rd, Roseville, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629798889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 86629 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Knarik Yegiazaryan, PHARMD 1304 Greenhills Rd, Sacramento, CA 95864-2780 Ph: (916) 803-0881 | Knarik Yegiazaryan, PHARMD 1600 Eureka Rd, Roseville, CA 95661-3027 Ph: (916) 784-4000 |
News Archive
Pregnant women with bipolar disorder and their families and physicians should be aware of a significantly higher risk for developing postpartum psychosis, according to a new Northwestern Medicine review of literature on the rare and under-researched disorder.
Celladon Corp. announced today that the United States Patent and Trademark Office (USPTO) has granted a notice of allowance for a broad patent covering the company's lead drug candidate MYDICAR®, a genetically targeted enzyme replacement therapy for advanced heart failure. The patent will be issued to The Regents of the University of California and licensed exclusively to Celladon.
QLT Inc. today announced that it has initiated enrollment in a Phase Ib trial of QLT091001 in pediatric patients with Leber Congenital Amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
Mayo Clinic researchers have discovered the mechanisms behind two key checkpoints in cell growth and development - factors that may ultimately allow investigators to benchmark progression of tumor cells or stop them from further development.
Type 1 diabetes, an autoimmune disease that typically emerges before the age of 20, wipes out the body's ability to produce insulin-a hormone that's essential to life. Diagnosis often comes after symptoms arise, at which point the disease has taken hold.
› Verified 6 days ago
Lynn Tuyet Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 | |
Carol Lynn Schulz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4184 | |
Jessica Ng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-474-6555 | |
Dr. Mina Eskandar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1298 Antelope Creek Dr, #521, Roseville, CA 95678 Phone: 518-506-2513 | |
Madison Le, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9280 Sierra College Blvd, Roseville, CA 95661 Phone: 916-772-5313 | |
Mr. Joseph Chadwick Jacobs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 446 Roseville Sq, Roseville, CA 95678 Phone: 916-784-1590 Fax: 916-784-1728 | |
Saimah Arshad, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Riverside Ave, Roseville, CA 95678 Phone: 916-486-5256 |